PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF RECOMBINANT ZOSTER VACCINE FOR VACCINATING IMMUNOCOMPROMISED ADULTS AGAINST HERPES ZOSTER IN THE UNITED STATES

被引：0
|
作者：
Salem, A. [1 ]
Curran, D. [2 ]
Carrico, J. [3 ]
La, E. M. [4 ]
Lorenc, S. [2 ]
Hicks, K. [3 ]
Poston, S. [4 ]
Carpenter, C. F. [5 ]
机构：
[1] GSK, Sint Agatha Berchem, Belgium
[2] GSK, Wavre, Belgium
[3] RTI Hlth Solut, Res Triangle Pk, NC USA
[4] GSK, Philadelphia, PA USA
[5] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE526
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF VACCINATING AGAINST HERPES ZOSTER WITH ADJUVANTED RECOMBINANT ZOSTER VACCINE IN SWITZERLAND
    Nishimwe, M. L.
    Fischer, L.
    Kientsch, U.
    Giannelos, N.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S71 - S71
  • [2] Cost-Effectiveness Analysis of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Immunocompromised Adults Diagnosed with Select Cancers in the United States
    Curran, Desmond
    Patterson, Brandon
    Carrico, Justin
    Salem, Ahmed
    La, Elizabeth
    Lorenc, Stephane
    Hicks, Katherine
    Poston, Sara
    Carpenter, Christopher
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 : S26 - S26
  • [3] Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States
    Ahmed Salem
    Elizabeth M. La
    Desmond Curran
    Brandon J. Patterson
    Justin Carrico
    Stéphane Lorenc
    Katherine A. Hicks
    Sara Poston
    Christopher F. Carpenter
    [J]. PharmacoEconomics - Open, 2023, 7 : 975 - 985
  • [4] Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States
    Salem, Ahmed
    La, Elizabeth M.
    Curran, Desmond
    Patterson, Brandon J.
    Carrico, Justin
    Lorenc, Stephane
    Hicks, Katherine A.
    Poston, Sara
    Carpenter, Christopher F.
    [J]. PHARMACOECONOMICS-OPEN, 2023, 7 (06) : 975 - 985
  • [5] Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
    Curran, Desmond
    Patterson, Brandon J. J.
    Carrico, Justin
    Salem, Ahmed
    La, Elizabeth M. M.
    Lorenc, Stephane
    Hicks, Katherine A. A.
    Poston, Sara
    Carpenter, Christopher F. F.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [6] Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States
    Curran, D.
    Patterson, B.
    Varghese, L.
    Van Oorschot, D.
    Buck, P.
    Carrico, J.
    Hicks, K.
    Lee, B.
    Yawn, B.
    [J]. VACCINE, 2018, 36 (33) : 5037 - 5045
  • [7] Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States
    Lu, Angela
    Sun, Yuwei
    Porco, Travis C.
    Arnold, Benjamin F.
    Acharya, Nisha R.
    [J]. OPHTHALMOLOGY, 2021, 128 (12) : 1699 - 1707
  • [8] Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
    Giannelos, Nikolaos
    Ng, Cheryl
    Curran, Desmond
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [9] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF HERPES ZOSTER VACCINATION FOR OLDER ADULTS IN THE NETHERLANDS
    Van der Pol, S.
    Giannelos, N.
    Joost, S.
    Wilschut, J. C.
    Post, M. J.
    Boersma, C.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S133 - S133
  • [10] Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
    Ashleigh McGirr
    Desiree Van Oorschot
    Robyn Widenmaier
    Michael Stokes
    Michael L. Ganz
    Hyosung Jung
    Lijoy Varghese
    Desmond Curran
    [J]. Applied Health Economics and Health Policy, 2019, 17 : 723 - 732
12345